Press Releases

Month Year

Month Year

Investor Alerts

Aug 9, 2021

Trevi Therapeutics Announces Additions to the Senior Leadership Team

Key Management Appointments Support Company Growth as Lead Trials Move Towards Data
Aug 5, 2021

Trevi Therapeutics to Report Q2 2021 Financial Results on August 12

Conference Call and Webcast to be Held at 4:30 p.m. ET
Jun 9, 2021

Trevi Therapeutics to Present at 2021 BIO Digital Conference
May 13, 2021

Trevi Therapeutics Announces First Quarter 2021 Financial Results and Business Update

Phase 2b/3 PRISM (Chronic Pruritus in PN) Trial Over 70% Enrolled
May 6, 2021

Trevi Therapeutics to Report Q1 2021 Financial Results on May 13

Conference Call and Webcast to be Held at 4:30 p.m. ET
Apr 7, 2021

Trevi Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
Mar 25, 2021

Trevi Therapeutics Announces Fourth Quarter and Year End 2020 Financial Results and Business Updates
Mar 18, 2021

Trevi Therapeutics to Report Q4 and Year End 2020 Financial Results on March 25
Feb 18, 2021

Trevi Therapeutics to Present at 10th Annual SVB Leerink Global Healthcare Conference
Feb 1, 2021

Trevi Therapeutics Appoints William Forbes, Pharm.D. as Chief Development Officer

Show per page

Media Contact

Katie Barrett
(203) 903-9627
k.barrett@trevitherapeutics.com

Trevi Therapeutics
195 Church Street, 16th Floor
New Haven, CT 06510
map